NATTY LAB CO SITE LAUNCH
USE CODE: FREESHIP250 FOR FREE SHIPPING OVER $250
NATTY LAB CO SITE LAUNCH
USE CODE: FREESHIP250 FOR FREE SHIPPING OVER $250
Last Updated: January 22, 2026
In any serious research environment, documentation is not optional — it is foundational. One of the most critical documents accompanying any research compound is the Certificate of Analysis (COA). For researchers sourcing peptides, a COA is not a marketing add-on; it is the primary mechanism for verifying identity, purity, and consistency before a compound is ever introduced into a study.
At Natty, COAs are treated as essential research documentation, not promotional material. They exist to support traceability, reproducibility, and responsible handling within laboratory settings.
A legitimate Certificate of Analysis provides third-party verification of key analytical attributes, which typically include:
Compound identity confirmation using validated analytical methods
Purity measurements determined through chromatography or spectroscopy
Batch or lot identification, enabling traceability back to a specific production run
Testing methodology references, including instrumentation and standards used
Laboratory credentials associated with the testing facility
Without this documentation, researchers are forced to rely on unverified claims — a risk that undermines both data integrity and experimental repeatability.
Research peptides are not approved drugs, supplements, or medical treatments. They are produced and distributed strictly for laboratory research use only (RUO). This distinction is critical and intentional.
RUO designation exists because:
These compounds have not undergone FDA approval for human use
They are not manufactured under pharmaceutical GMP drug standards
Safety, dosage, and efficacy have not been established for ingestion or injection
They are intended solely for in vitro, analytical, or preclinical research contexts
Attempting to repurpose research peptides for personal use bypasses regulatory safeguards designed to protect human health and compromises the integrity of legitimate research ecosystems. Natty maintains strict adherence to RUO classification to ensure clarity, compliance, and responsible distribution.
Independent laboratory testing is a cornerstone of responsible peptide sourcing. Reputable third-party laboratories operate independently from manufacturers and distributors, reducing conflicts of interest and increasing confidence in analytical results.
High-standard testing laboratories typically adhere to practices such as:
Validated analytical methods (e.g., HPLC, LC-MS, NMR where applicable)
Controlled sample handling and documentation protocols
Internal quality systems and calibration standards
Clear reporting tied to specific batch or lot numbers
The presence of third-party testing does not imply suitability for human use — rather, it provides researchers with objective data needed to evaluate whether a compound meets the specifications required for their experimental design.
Batch-level traceability is often overlooked, yet it is one of the most important elements of responsible research sourcing. A COA tied to a specific lot ensures that:
Results can be replicated using the same material profile
Variations between production runs can be identified and accounted for
Documentation remains aligned with the exact compound received
At Natty, batch identification and documentation are treated as non-negotiable components of research transparency.
Research environments depend on precision, accountability, and verification. COAs, RUO designation, third-party testing, and batch traceability all serve a single purpose: enabling researchers to make informed, responsible decisions based on documented evidence rather than assumptions.
Natty exists to support that standard — not by making claims, but by providing access to clearly documented research materials designed for controlled laboratory use.
Responsible research starts with documentation.
